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Abstract
Background:  Several minimally invasive saphenous vein harvesting techniques have been
developed to reduce morbidities associated with coronary artery bypass grafting. This prospective,
randomized study was designed to compare two commonly used minimally invasive saphenous vein
harvesting techniques, the SaphLITE Retractor System (Teleflex Medical) and the Clearglide
Endoscopic Vessel Harvesting System (Ethicon CardioVations, Inc.).
Methods: Between January 2003 and March 2004, a total of 200 patients scheduled for primary,
nonemergent coronary artery bypass grafting, with or without concomitant procedures were
randomized into two groups: SaphLITE (n = 100) and Clearglide (n = 100). Pre-, intra- and
postoperative data was collected and subjected to statistical analysis. Randomization provided
homogenous groups with respect to preoperative risk factors.
Results: Harvest location for the SaphLITE group was thigh (n = 40), lower leg (n = 5) and both
lower leg and thigh (n = 55). The location of harvest for the Clearglide group was thigh (n = 3),
lower leg (n = 16) and both lower leg and thigh (n = 81). The mean incision length was 3.6 cm
(range, 2–6) in the SaphLITE group versus 2.1 cm (range, 1–4) in the Clearglide group (p < 0.05).
The total incision length was 12.9 cm versus 8.9 (p < 0.05) in the SaphLITE and Clearglide groups.
Conversion to the open technique occurred in 5 SaphLITE patients and 7 Clearglide patients.
Intraoperative leg exploration for bleeding occurred in two of the Clearglide patients and none of
the SaphLITE patients. Post-operative complications specifically related to minimally invasive
harvesting technique, including a two-week post-discharge visit, were not statistically different
between the groups.
Conclusion: The saphenous vein can be safely harvested utilizing the SaphLITE and Clearglide
systems. While the Clearglide system allows for fewer incisions (number and length) and less
harvest time, these benefits may be outweighed by the increased cost of the Clearglide system
compared to the SaphLITE retractor.
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Background
Coronary artery bypass grafting (CABG) is the most fre-
quently performed cardiac surgical procedure in the
world. There are approximately 467,000 CABG proce-
dures performed in this country annually [1]. Along with
the internal mammary and radial arteries, the greater
saphenous vein (SV) is a commonly used conduit in
CABG. Historically, the incision required for the removal
of the SV has been 30–45 cm long and may at times
extend from the thigh to the ankle. As a result, the harvest
of the SV is commonly associated with increased morbid-
ity including but not limited to pain, discomfort, scarring
and the increased risk of wound infection. Wound mor-
bidity rates of up to 24% have been reported with conven-
tional (longitudinal) SV harvest techniques [2-9].
Occurrence of these events often negatively affects the
patient's recovery phase and dominates the rehabilitative
process [10].
During the past decade, several minimally invasive vein
harvesting techniques have been developed to reduce
morbidities associated with saphenous vein removal [11].
Minimally invasive procedures have demonstrated several
advantages including reduced incidence of wound com-
plications, decreased hospital length of stay, reduced scar-
ring, etc. [12,13]. These potential benefits have prompted
surgical groups to further explore minimally invasive har-
vest techniques (MIHT) and to discern their impact on
health-care savings. In today's cost-containment environ-
ment, resource utilization becomes an important factor in
the selection of an appropriate system.
The application of minimally invasive harvest is rapidly
becoming the standard of care in most cardiac surgical
practices. However, the efficacy, unresolved clinical con-
cerns and cost benefits of various approaches have not
been well-defined. This study examines clinical outcomes
and discerns the cost benefits attributed to each of the
technologies.
Methods
Study design
This was a prospective, randomized study comparing the
use of two commonly-used MIHT. Random assignment
was performed by means of drawing a sealed, unlabeled,
unordered envelope from a container in the operating
room. Patients were randomly assigned to one of two har-
vest techniques: the Teleflex Medical SaphLITE Retractor
(SVH) or the Ethicon Cardiovations Clearglide Endo-
scopic Vessel Harvesting System (CVH). All patients in the
study gave written, informed consent. This study was
approved by the Institutional Review Board at Naples
Community Hospital.
Inclusion criteria
Men and women 18 years of age or over undergoing elec-
tive or urgent CABG or CABG with a concomitant proce-
dure, e.g., valve repair, valve replacement, etc were eligible
for participation. Patients had to be willing and able to
provide informed consent and to adhere to the required
follow-up.
Exclusion criteria
Patients with morbid obesity (greater than 20% of ideal
body weight), prior vein stripping and ligation, severe var-
icosities, preoperative infection or sepsis, evidence of leg
ulcers and/or a surgical category of emergent or salvage
were excluded from enrollment in the study. In addition,
patients with previous CABG were also excluded.
Patient population
From January 2003 to March 2004, 200 patients undergo-
ing isolated CABG or CABG with a concomitant proce-
dure, e.g., valve repair, valve replacement, etc. comprised
the clinical material for this report. The SVH group was
comprised of 81 men (81.0%) and 19 women (19.0%)
with a mean age of 68.6 ± 9.4 years (range, 43–88 years).
The CVH group included 80 men (80.0%) and 20 women
(20.0%) with a mean age of 70.3 ± 9.4 years (range, 49–
90 years). The clinical characteristics of the two patient
groups are listed in Table 1. Based on the preoperative
clinical characteristics measured, the study groups were
comparable.
Definitions
Postoperative vein harvest site morbidities
Erythema  referred to redness of the skin. Ecchymosis
referred to a small hemorrhagic spot, larger than a
petechia, in the skin or mucous membrane forming a
nonelevated, rounded or irregular, blue or purplish patch.
Fluctuance referred to a palpable indication of the pres-
ence of pus in a bacterial infection. Hematoma referred to
a localized collection of blood. Seroma referred to a collec-
tion of serum in the tissues. Wound dehiscence referred to
a superficial, partial or complete separation of the layers
of a surgical wound. Cellulitis referred to an acute, diffuse,
spreading, edematous, inflammation of deep subcutane-
ous tissues. Blisters  referred to a vesicle having either
watery or bloody contents. Leg (harvest site) infection
referred to an infection involving a leg vein harvest site
and which must have had either the wound opened with
excision of tissue, positive culture or treatment with anti-
biotics.
Vein harvesting technique
All conduits are harvested by experienced physician assist-
ants. The legs are prepped with chlorhexidine gluconate
and betadine and draped with Ioban. The legs are then
inspected for varicosities and a harvest site selected. A 2–Journal of Cardiothoracic Surgery 2006, 1:24 http://www.cardiothoracicsurgery.org/content/1/1/24
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3 cm incision is made below the knee medial to the tibia
or above the knee at the medial inner thigh. Blunt dissec-
tion is performed to locate the greater SV.
Ethicon clearglide endoscopic approach
The Clearglide Optical Vessel Dissector was then placed
over a 30 degree angle scope and attached to an endo-
scopic camera. The dissector allows for smooth atraumatic
dissection on the anterior and lateral surfaces of the SV
and creates a cavity for instrument passage. The dissector
is then removed and the ultra-retractor is placed over the
scope and into the tunnel. The retractor is then advanced
until a side branch is identified. An Allport endoscopic
clip applier is then used to clip the branch distally from
the vein and endoscopic scissors are used to ligate the
branch. This process is repeated distally and proximally
through the tunnel as long as the length of the retractor
allows until all side branches are secured. A metal vessel
dissector hook is then used to assure that all side branches
are ligated before transecting and removing the SV. A
metal clip is then placed at the distal end of the vein
allowing transaction and removal through the initial inci-
sion. A stab incision is then made proximally and the SV
identified and secured with a 0-silk and/or metal clip,
transected and finally removed.
Teleflex medical SaphLITE approach
The SaphLITE self-retaining system is attached to the oper-
ative bed to allow hands-free retraction and visualization.
A disposable light panel is fit into a blade, which is
attached to the SaphLITE retractor. The retractor is then
inserted into the tunnel and gently advanced for direct vis-
ualization of the SV. A metal hook dissector and scissors
are used to dissect the SV and to identify side branches.
Once identified, branches are clipped with metal clips and
ligated. Once the end of the blade is reached, another inci-
sion is made if additional vein length is required. Blunt
dissection is again used to identify the SV and to create a
tunnel. This process is continued proximally and distally
until the desired length of SV is obtained. The harvested
vein is then ligated at both ends with a 0-silk and/or metal
clip, transected and removed.
Following the application of either harvesting technique,
the vein is prepared to be used as a conduit for CABG. A
plastic cannula is inserted into the distal end of the SV and
a solution of albumin, heparin and saline is used to flush
out the SV. Side branches are tied with 3-0 silk and/or
clipped with metal clips.
Operative data
The left leg was the harvest site for 97 patients (97.0%) in
each group. Five patients (5.0%) were converted to an
open approach in the SVH group and 7 patients (7.0%) in
the CVH group. The SV quality was ideal in 51 patients
(51.0%) in the SVH group and in 37 patients (37.0%) in
the CVH group. Moreover, the SV quality was found to be
acceptable in 44 patients (44.0%) in the SVH group and
in 55 (55.0%) in the CVH group. In 5 patients (5.0%) in
the SVH group and 8 patients (8.0%) in the CVH group,
the SV was of poor quality. There was no re-exploration
for bleeding in the SVH group; however, 2 patients (2.0%)
in the CVH group had excessive bleeding and required re-
exploration. Information on selected intraoperative varia-
bles is presented in Table 2.
In the SVH group, the number of incisions performed and
the total incision length was significantly higher (p =
0.001) than in the CVH group. Moreover, in the CVH
group the length of the SV harvested was significantly
greater (p = 0.010) than in the SVH group. The total SV
harvest time was significantly greater (p = 0.014) in the
SVH group than in the CVH group. The SV was removed
at a rate of 0.80 cm/minute with the SVH compared to
1.04 cm/minute with the CVH. Harvest with the SVH
required fewer repairs; however this difference did not
achieve statistical significance.
Table 1: Medical History Information by Patient Group*
Variables SaphLITE (n = 100) Clearglide (n = 100) p Value
Smoking history 54 (54.0) 49 (49.0) 0.479
Chronic obstructive pulmonary disease 11 (11.0) 10 (10.0) 0.818
Diabetes mellitus 33 (33.0) 34 (34.0) 0.881
Renal insufficiency 6 (6.0) 2 (2.0) 0.149
Peripheral vascular disease 10 (10.0) 16 (16.0) 0.207
History of deep vein thrombosis 2 (2.0) 0 (0.0) 0.155
Varicose veins (current) 0 (0.0) 4 (4.0) 0.043
Steroids/Immunosuppressant Therapy 1 (1.0) 1 (1.0) 1.000
IIb/IIIa platelet inhibitors 7 (7.0) 2 (2.0) 0.088
Antiplatelet therapy 79 (79.0) 82 (82.0) 0.592
Antithrombotic therapy 35 (35.0) 24 (24.0) 0.088
* Data are expressed as No. (%).Journal of Cardiothoracic Surgery 2006, 1:24 http://www.cardiothoracicsurgery.org/content/1/1/24
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Data collection and management
Preoperative, intraoperative, postoperative and follow-up
data collection was accomplished for each patient partici-
pating in the study. Data were obtained by prospective
review of the patient's hospital record, catheterization
reports, echocardiography and pathology reports apply-
ing a standardized methodology and definition of terms.
The principle research technique involved the completion
of a Saphenous Vein Harvest Study-Hospital Case Report Form
during the patient's hospitalization. Moreover, a Follow-up
Case Report Form was completed during the patient's office
follow-up visit at 2 weeks post-discharge. A Telephone Fol-
low-up Report Form was completed with information col-
lected through a telephone interview conducted at 12
weeks post-discharge from the hospital.
All follow-up information was obtained through direct
patient contact, family members or the patient's personal
physician. The use of these data collection instruments
provided for standardized reporting of each patient's clin-
ical status before and after the operation. Follow-up was
98.0% complete in the SVH group with 2 patients being
lost to follow-up after discharge from the hospital. In the
CVH group, follow-up was 100.0% complete with no
patients lost after discharge from the hospital. Data col-
lected were entered into a Microsoft Excel spreadsheet
(Microsoft Inc.) and subsequently retrieved for analysis.
Statistical methods
Data are presented as frequency distributions and simple
percentages. Values of continuous variables are expressed
as mean ± standard deviation. Univariate analysis of
selected preoperative and postoperative discrete variables
was accomplished by chi-square, the continuity-adjusted
chi-square analysis or a two-tailed Fisher's exact test with
the appropriate degrees of freedom to test for the equality
of proportions in the case of categorical variables. Com-
parison of means for continuous variables was conducted
by an unpaired Student's t-test. A significant difference
between measurements was defined as p less than or equal
to 0.05. Data collected were subjected to both quantitative
and qualitative analysis using the Number Cruncher Statis-
tical Systems (NCSS), Kaysville, UT.
Results
In-hospital events
The hospital mortality rate for the SVH group was 3.0%
(3/100) and 2.0% (2/100) for the CVH group. The overall
hospital mortality rate for the series was 2.5% (5/200).
The hospital morbidities relating to the SV harvest site for
the two groups are presented in Table 3. There were no sig-
nificant differences in the occurrence rate of postoperative
harvest site morbidities between the groups. Except for the
occurrence of ecchymosis, the overall rate of occurrences
of harvest site complications was low for both groups.
Table 3: Leg Wound Appearance Following Hospital Discharge by Patient Group*
In-Hospital Office Follow-up
Variables SaphLITE (n = 100) Clearglide (n = 100) p Value SaphLITE (n = 95) Clearglide (n = 96) p Value
Erythema 5 (5.0) 2 (2.0) 0.243 7 (7.4) 10 (10.4) 0.459
Echymosis 19 (19.0) 20 (20.0) 0.886 8 (8.4) 8 (8.3) 0.983
Hematoma 2 (2.0) 1 (1.0) 0.555 3 (3.2) 1 (1.0) 0.307
Seroma 2 (2.0) 2 (2.0) 0.992 2 (2.1) 4 (4.2) 0.414
Wound dehiscence 0 (0.0) 0 (0.0) -- 1 (1.1) 1 (1.0) 0.994
Cellulitis 3 (3.0) 0 (0.0) 0.079 1 (1.1) 3 (3.1) 0.317
Wound drainage 4 (4.0) 1 (1.0) 0.171 2 (2.1) 4 (4.2) 0.414
Blisters 0 (0.0) 1 (1.0) 0.319 1 (1.1) 0 (0.0) 0.314
Leg (harvest site) infection 0 (0.0) 0 (0.0) -- 0 (0.0) 1 (1.0) 0.319
* Data are expressed as No. (%).
Table 2: Vein Harvest Intraoperative Variables by Patient Group*
Variables SaphLITE (n = 100) Clearglide (n = 100) p Value
Number of incisions performed 3.6 ± 1.1 2.1 ± 0.8 0.001
Total incision length (cm) 12.9 ± 5.6 9.0 ± 9.1 0.001
Length of saphenous vein harvested (cm) 38.5 ± 12.9 43.5 ± 13.6 0.010
Total saphenous vein harvest time (min) 47.6 ± 17.2 41.8 ± 16.8 0.014
Number of saphenous veins repaired 0.8 ± 1.1 1.1 ± 1.2 0.084
* Values given as mean ± SD.Journal of Cardiothoracic Surgery 2006, 1:24 http://www.cardiothoracicsurgery.org/content/1/1/24
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The assessment of leg edema on a scale of 0 to 4, with 0
representing no edema and 4 representing severe edema,
was similar for the two groups. In the SVH group 84
patients (86.1%) and 83 patients (84.7%) in the CVH
group had no edema (mean, 0.144 versus 0.214 respec-
tively). Information concerning the patient's ability to
ambulate following surgery revealed similar outcomes.
Fifty-three patients (54.6%) in the SVH group and 56
patients (57.1%) in the CVH group were able to ambulate
on the first postoperative day (mean, 1.9 days versus 2.0
days respectively).
At hospital discharge, the patient's leg pain was assessed
on a scale of 0 to 10 with 0 representing no pain and 10
the worst pain. In the SVH group, 70 patients (72.0%) and
69 patients (70.0%) in the CVH group reported no pain
(mean, 0.526 versus 0.592 respectively). The mean post-
operative length of stay for patients in the SVH group was
6.8 ± 5.0 days and 7.3 ± 4.4 days for the CVH group. This
difference did not achieve statistical significance.
Patient follow-up
Office follow-up was conducted at 2 weeks post-discharge
from the hospital. Two patients (2.1%) in the SVH group
and 7 patients (7.3%) in the CVH group required antibi-
otic therapy. Seventy-six patients (80.0%) in the SVH
group and 81 patients (84.4%) in the CVH group were
completely healed when seen at office follow-up. Leg
wound appearance was assessed at the office follow-up by
patient group (see Table 3). No significant difference was
noted in the various factors assessed between the groups
in leg wound appearance.
The assessment of leg edema at office follow-up was con-
ducted using a scale of 0 to 4, with 0 representing no
edema and 4 representing severe edema. In the SVH
group, 76 patients (80.0%) and 70 patients (72.9%) in
the CVH group had no edema (mean, 0.231 versus 0.365
respectively). An assessment of leg pain was performed at
office follow-up, utilizing a scale of 0 to 10 with 0 repre-
senting no pain and 10 the worst pain. In the SVH group,
69 patients (72.6%) and in the CVH group 71 patients
(74.0%) reported no pain (mean, 0.526 versus 0.592
respectively). Ambulation assessment at 2 weeks post dis-
charge revealed that 59 patients (62.1%) in the SVH group
and 58 patients (60.4%) were walking more than a half-
mile per day.
At 12 weeks following discharge from the hospital, a tele-
phone interview was conducted with each patient. There
were 3 patients (3.2%) in the SVH group and 2 patients
(2.6%) in the CVH group who were receiving antibiotic
therapy for leg related problems. Moreover, only 1 patient
(1.1%) in the SVH group and no patients in the CVH
group underwent incision and drainage for seroma.
Leg pain assessment at telephone follow-up found 77
patients (81.1%) in the SVH group and 77 patients
(78.6%) in the CVH group experiencing no pain (0.368
versus 0.398) respectively. There were 71 patients
(74.7%) in the SVH group and 66 patients (67.3%) in the
CVH group who were walking more than a half-mile per
day. No patient in either group required a hospital
readmission for leg wound complications.
Cost-benefit analysis
The capital cost for the purchase of the SVH system is
approximately $19,235 whereas the cost of the CVH sys-
tem is $30,000. This includes the 30 degree videoscope
and video equipment. In addition, a monitor system is
required for the CVH system which adds an additional
$2,500 to the overall cost of the system. As for the cost per
case, the SVH system requires a light panel which is $210
versus $509 for the CVH system which includes a vessel
dissector, ultra retractor, endoscopic clip applier and
endoscopic scissors. Excluding the cost of capital equip-
ment, the disposable supplies for the present study was
$21,000 for the SVH system versus $50,900 for the CVH
system. This results in a cost savings of $29,100 for the
200 patients participating in the present study and dem-
onstrates a financial benefit for the use of the SVH system
when compared to the CVH approach.
Discussion
During the past decade, major advances have been made
in the application of minimally invasive technology in
cardiovascular surgery. Minimally invasive SV harvesting
has become a standard of care at most institutions. It is
associated with diminished morbidity, decreased postop-
erative pain, improved cosmesis and reduced the rate of
readmission for leg wound complications [14-16]. As a
result, health care costs may be reduced and patient's sat-
isfaction and quality of life should be improved.
These benefits to the patient and the health care organiza-
tion must be considered against the increased costs asso-
ciated with MIHT. Moreover, these initial benefits of the
procedure must be considered in concert with long-term
graft patency. Some investigators have expressed concern
regarding vein integrity with the use of less invasive meth-
ods of SV harvesting [12,17]. However, Fabricius et al [18]
and Griffith et al [19] have documented minimal mor-
phologic differences in histology when comparing the
application of minimally invasive techniques in SV har-
vest with the traditional open approach.
This study has clearly demonstrated the benefits, safety
and efficacy of SV harvesting utilizing the SVH or the CVH
system. It must be recognized that these approaches to SV
harvesting are technically demanding and involve a learn-
ing curve. To avoid any concern regarding the technicalJournal of Cardiothoracic Surgery 2006, 1:24 http://www.cardiothoracicsurgery.org/content/1/1/24
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competence of the harvesters (physician assistants) in the
present study, they were required to perform 50 cases with
each system prior to the conduct of the study.
The conversion to an open approach was low in the
present study, with 5 patients (5.0%) in the SVH group
and 7 patients (7.0%) in the CVH group converted to an
open approach. These results are comparable to those
reported by Crouch et al [20] who documented a conver-
sion rate of 7.2% (13/180) and Allen et al [12] who indi-
cated a 5.6% rate (3/54). Conversion to an open approach
often occurs when visualization through the camera
becomes difficult as a result of bleeding. Moreover, con-
versions may be a function of patients having minimal
subcutaneous tissue or those with fragile veins. Our pro-
tocol requires that the procedure be converted to an open
technique any time the SV being harvested is compro-
mised or at risk for injury.
Significant differences were noted between the groups
based on intraoperative variables. The SVH group had a
greater number of incisions than the CVH group (p =
0.001). This is to be expected as the CVH system has a
greater length than the SVH. Moreover, the total incision
length was greater for the SVH group than the CVH group
(p = 0.001). The length of SV harvested was greater with
the CVH techniques and the time to perform the harvest
was also shorter (p = 0.014). A greater number of saphen-
ous veins were repaired in the CVH group (1.1 ± 1.2) than
in the SVH group (0.8 ± 1.1). However, this difference did
not achieve statistical significance. The number of SV
repairs in the present series was lower than that previously
reported [21].
Early postoperative (in-hospital) leg wound appearance
demonstrated no significant difference between the
groups. At office follow-up, again no significant difference
in leg wound appearance was noted in the two groups.
Similar results were also reported at telephone follow-up.
No patient in either group required a hospital readmis-
sion for leg wound complications. These outcomes are
more favorable than those reported in similar studies of
minimally invasive SV harvesting [22-24]. The assessment
of leg wound pain between the groups revealed no signif-
icant difference with the majority of patients reporting no
pain. Similar findings were documented at telephone fol-
low-up. Minimal to non-existent perceived leg pain has
been previously reported using minimally invasive SV
harvesting systems [25,26].
The SVH harvest technique was more time consuming
than the CVH approach (p = 0.014). However the time
difference for the two approaches was approximately 6
minutes and did not delay, in any manner, the surgical
procedure. As a result, harvest time should not be a factor
in selecting an appropriate SV harvesting system.
In today's cost containment health care environment, the
SVH approach offers an attractive alternative when com-
pared to the increased per-case cost of the CVH system.
However, the CVH system allows for fewer incisions
(number and length) and less harvest time. Based on
these findings, it may be that the use of these two systems
should be individualized based on the patient's require-
ments.
With the SVH system, there is a tendency to harvest thigh
vein, whereas there is a tendency to use the CVH system
for the lower leg. In cases where it is documented or sus-
pected that severe peripheral vascular disease exists below
the knee and one to two segments of SV are needed, the
SVH system appears to be the approach of choice. Further-
more, if only one segment of SV is required, the SVH sys-
tem should be considered for harvesting above the knee.
On the other hand, if an entire leg of SV vein is required,
the application of CVH technology is the application of
choice. The surgeon must weight the available options
and select the system based on the individualized needs of
the patient.
Conclusion
Minimally invasive SV harvesting is a safe and effective
technique to secure the required conduit for CABG. This
approach increases patient satisfaction, enhances quality
of life and provides for less pain and scarring to the indi-
vidual.
This study has demonstrated that the two minimally inva-
sive methods of SV harvesting have comparable out-
comes. However, the CVH system has an added cost that
must be factored into the selection algorithm in today's
cost-conscious health care environment.
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